Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

被引：0
|
作者：
Chandler S. Cortina
Jan Irene Lloren
Christine Rogers
Morgan K. Johnson
Adrienne N. Cobb
Chiang-Ching Huang
Amanda L. Kong
Puneet Singh
Mediget Teshome
机构：
[1] Medical College of Wisconsin,Division of Surgical Oncology, Department of Surgery
[2] Medical College of Wisconsin Cancer Center,Division of Biostatistics, Joseph J. Zilber School of Public Health
[3] University of Wisconsin-Milwaukee,Department of Breast Surgical Oncology
[4] University of Texas MD Anderson Cancer Center,undefined
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3128 / 3140
页数：12
相关论文
共 50 条
  • [1] ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
    Chandler S. Cortina
    Jan Irene Lloren
    Christine Rogers
    Morgan K. Johnson
    Adrienne N. Cobb
    Chiang-Ching Huang
    Amanda L. Kong
    Puneet Singh
    Mediget Teshome
    [J]. Annals of Surgical Oncology, 2024, 31 (6) : 3954 - 3955
  • [2] Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
    Cortina, Chandler S.
    Lloren, Jan Irene
    Rogers, Christine
    Johnson, Morgan K.
    Cobb, Adrienne N.
    Huang, Chiang-Ching
    Kong, Amanda L.
    Singh, Puneet
    Teshome, Mediget
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (5) : 3128 - 3140
  • [3] Does Neoadjuvant Chemotherapy in Clinical T1-2 N0 Triple-Negative Breast Cancer Facilitate De-Escalation of Axillary Surgery?
    Cortina, Chandler
    Rogers, Christine C.
    Lloren, Jan I.
    Johnson, Morgan
    Cobb, Adrienne N.
    Huang, Chuang-Ching
    Singh, Puneet
    Kong, Amanda L.
    Teshome, Mediget
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S43 - S43
  • [4] Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
    Hao, Qian
    Dai, Luyao
    Chang, Lidan
    Song, Dingli
    Liu, Dandan
    Ma, Xiaobin
    Wu, Hao
    Kang, Huafeng
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer
    Connor, Carol S.
    Kimler, Bruce
    Mammen, Joshua M.
    McGinness, Marilee K.
    Wagner, Jamie L.
    Alsop, Samantha M.
    Ward, Claire
    Fabian, Carol
    Khan, Qamar
    Sharma, Priyanka
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 38 - 39
  • [6] T1 N0 Triple Negative Breast Cancer: A Bad Actor
    Livingston, Robert
    [J]. BREAST JOURNAL, 2009, 15 (05): : 451 - 453
  • [7] Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
    Zhai, Zhen
    Zheng, Yi
    Yao, Jia
    Liu, Yu
    Ruan, Jian
    Deng, Yujiao
    Zhou, Linghui
    Zhao, Peng
    Yang, Si
    Hu, Jingjing
    We, Bajin
    Wu, Ying
    Zhang, Dai
    Kang, Huafeng
    Dai, Zhijun
    [J]. JAMA NETWORK OPEN, 2020, 3 (11)
  • [8] Benefit of Adjuvant Chemotherapy in T1 N0 Triple Negative Breast Cancer Stratified by Tumor Size
    Fasano, G. A.
    Bayard, S.
    Chen, Y.
    Davis, M.
    Varella, L.
    Cigler, T.
    Simmons, R.
    Swistel, A.
    Marti, J.
    Ng, J.
    Brandmeier, A.
    Formenti, S.
    Newman, L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S64 - S64
  • [9] Extent of Breast Surgery After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Benson, John R.
    Dumitru, Dorin
    [J]. JAMA SURGERY, 2020, 155 (08) : 784 - 785
  • [10] Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
    Andreis, D.
    Bonardi, S.
    Allevi, G.
    Aguggini, S.
    Gussago, F.
    Milani, M.
    Strina, C.
    Spada, D.
    Ferrero, G.
    Ungari, M.
    Rocca, A.
    Nanni, O.
    Roviello, G.
    Berruti, A.
    Harris, A. L.
    Fox, S. B.
    Roviello, F.
    Polom, K.
    Bottini, A.
    Generali, D.
    [J]. BREAST, 2016, 29 : 55 - 61
12345